Merit Medical Systems, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Martha Goldberg Aronson
- Full Time Employees
- 7,400
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 1600 West Merit Parkway South Jordan UT United States of America 84095
- IPO Date
- May 14, 1990
- CIK
- 0000856982
- Website
- merit.com
- Similar Companies
- Business
- Merit Medical Systems, Inc. is a leading worldwide designer, developer, manufacturer, and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987 and headquartered in South Jordan, Utah, the company operates in two primary segments, Cardiovascular and Endoscopy, offering a broad portfolio of products including micropuncture kits, angiographic needles, sheaths, guidewires, safety devices, inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, thrombolytic catheters, fluid dispensing systems, angiography accessories, hemostatic solutions, and procedural kits for peripheral intervention, spine, and oncology applications; it serves hospitals, physicians, and clinicians globally with approximately 7,000 employees and manufacturing facilities worldwide. In May 2025, Merit acquired Biolife Delaware, L.L.C. for approximately $120 million in cash and assumed liabilities, adding the patented StatSeal and WoundSeal hemostatic products that address a $350 million global market opportunity and are projected to contribute $18 million in annual revenue starting in fiscal 2026; earlier transactions include the November 2024 acquisition of assets from Cook Medical Holdings LLC and the July 2024 acquisition of EndoGastric Solutions, Inc., alongside a signed asset purchase agreement in October 2025 for the C2 CryoBalloon from PENTAX Medical to expand its gastroenterology portfolio.
Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Merit Medical Systems, Inc. (MMSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Merit Medical Systems Inc (MMSI) Shares Fall 3.1% -- What GF Score of 79 Tells Investors
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Merit Medical to Participate in the Bank of America Healthcare Conference
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
A Look at Merit Medical Systems Inc (MMSI) After 3.4% Gain -- GF Value $96.06 vs Price $70.57
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?